Alembic Pharmaceuticals informs about press release

04 May 2021 Evaluate

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Metronidazole Gel USP, 1%. In this regard, the company has enclosed a press release on 4th May 2021 titled ‘Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Metronidazole Gel USP, 1%’.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

886.15 -0.40 (-0.05%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×